Giordano Nicoletti

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2001, The Journal of experimental medicine.

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2005, The American journal of pathology.

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.

Annalisa Astolfi, Anna Rocchi, Stefania Meschini, 2010, The Journal of clinical investigation.

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Ilaria Rossi, 1998, The Journal of experimental medicine.

Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2004, Cancer Research.

Inhibition of Lung Colonisation of a Mouse Mammary Carcinoma by Therapeutic Vaccination with Interferon-α Gene-Transduced Tumor Cells

Flavia Frabetti, Filippo Belardelli, Piero Musiani, 1998, Clinical & Experimental Metastasis.

Vaccines and other immunological approaches for cancer immunoprevention.

Federica Cavallo, Patrizia Nanni, Guido Forni, 2011, Current drug targets.

A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function.

Giovanni Romeo, Giuseppe Gasparre, Anna Ghelli, 2011, Cancer research.